Citation Impact

Citing Papers

Outcomes Associated With Apixaban Use in Patients With End-Stage Kidney Disease and Atrial Fibrillation in the United States
2018
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
Effect of a Home-Based Wearable Continuous ECG Monitoring Patch on Detection of Undiagnosed Atrial Fibrillation
2018
Short sleep duration and cardiometabolic risk: from pathophysiology to clinical evidence
2018
High Diagnostic Yield and Accuracy of History, Physical Examination, and ECG in Patients with Transient Loss of Consciousness in FAST: The Fainting Assessment Study
2007
The three human monocyte subsets: implications for health and disease
2012
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Non-Alcoholic Fatty Liver Disease as a Predictor of Atrial Fibrillation in Middle-Aged Population (OPERA Study)
2015
From Monocytes to M1/M2 Macrophages: Phenotypical vs. Functional Differentiation
2014 Standout
Chronic inflammation in the etiology of disease across the life span
2019 Standout
Dabigatran etexilate – a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity
2010 Standout
Explainability for artificial intelligence in healthcare: a multidisciplinary perspective
2020 Standout
Embolic strokes of undetermined source: the case for a new clinical construct
2014 Standout
Oral Anticoagulant Therapy
2012 Standout
The Global Impact of Rheumatic Heart Disease
2021
Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis
2016 Standout
Culprit Vessel Percutaneous Coronary Intervention Versus Multivessel and Staged Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction Patients With Multivessel Disease
2010
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
2013 Standout
Effect of pacing method on risk of sudden death after atrioventricular node ablation and pacemaker implantation in patients with atrial fibrillation
2013
Life’s Essential 8: Updating and Enhancing the American Heart Association’s Construct of Cardiovascular Health: A Presidential Advisory From the American Heart Association
2022 Standout
Combining Antiplatelet and Anticoagulant Therapies
2009
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Psychological Health, Well-Being, and the Mind-Heart-Body Connection: A Scientific Statement From the American Heart Association
2021
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
Multimodal biomedical AI
2022 Standout
Statin use and development of atrial fibrillation: A systematic review and meta-analysis of randomized clinical trials and observational studies
2007
Recent advances in the molecular pathophysiology of atrial fibrillation
2011
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 Standout
Efficacy and safety of oral anticoagulants in atrial fibrillation patients with cancer—a network meta-analysis
2019
Surgical Versus Percutaneous Revascularization for Multivessel Disease in Patients With Acute Coronary Syndromes
2010
How to treat patients with ST-elevation acute myocardial infarction and multi-vessel disease?
2010
Sleep-disordered breathing and chronic atrial fibrillation
2008
Artificial Intelligence in Cardiology
2018 Standout
Pulmonary Vein Stenosis Complicating Ablation for Atrial Fibrillation
2009
Dapagliflozin: A Review of Its Use in Patients with Type 2 Diabetes
2014
Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease
2018 Standout
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)
2011 Standout
NAFLD: A multisystem disease
2015 Standout
Cardiovascular Disease and Myocardial Abnormalities in Nonalcoholic Fatty Liver Disease
2016
Cardiac resynchronization therapy in patients undergoing atrioventricular junction ablation for permanent atrial fibrillation: a randomized trial
2011
Nonalcoholic fatty liver disease and increased risk of 1-year all-cause and cardiac hospital readmissions in elderly patients admitted for acute heart failure
2017
Antibody testing in aspergillosis—quo vadis?
2015
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Tirzepatide Once Weekly for the Treatment of Obesity
2022 Standout
Recent Innovations, Modifications, and Evolution of ACC/AHA Clinical Practice Guidelines: An Update for Our Constituencies: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Indoxyl Sulfate: A Novel Cardiovascular Risk Factor in Chronic Kidney Disease
2017
Occult Atrial Fibrillation in Cryptogenic Stroke
2013
Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial
2012
Recent Innovations, Modifications, and Evolution of ACC/AHA Clinical Practice Guidelines: An Update for Our Constituencies
2019
AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions
2017
Guidelines for the Primary Prevention of Stroke
2014 Standout
Interventions for improving modifiable risk factor control in the secondary prevention of stroke
2018
Evaluation of a Prediction Model for the Development of Atrial Fibrillation in a Repository of Electronic Medical Records
2016
Indications for Cardiac Catheterization and Intervention in Pediatric Cardiac Disease
2011 Standout
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Efficacy and safety of rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation and a history of cancer: observations from ROCKET AF
2018
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
An Update on the Prognosis of Patients With Atrial Fibrillation
2012
Identification of adenylate cyclase-coupled beta-adrenergic receptors with radiolabeled beta-adrenergic antagonists
1975 StandoutNobel
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
2017 Standout
Cardiovascular Health in African Americans: A Scientific Statement From the American Heart Association
2017
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Nonalcoholic Fatty Liver Disease Is Associated With Ventricular Arrhythmias in Patients With Type 2 Diabetes Referred for Clinically Indicated 24-Hour Holter Monitoring
2016
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Global burden of heart failure: a comprehensive and updated review of epidemiology
2022 Standout
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
2018 Standout
Obesity is associated with incident atrial fibrillation independent of gender: A meta‐analysis
2018
Practice advisory update summary: Patent foramen ovale and secondary stroke prevention
2020
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout

Works of Lin Y. Chen being referenced

Chronic Kidney Disease Is Associated With the Incidence of Atrial Fibrillation
2011
Abdominal Obesity is an Independent Risk Factor for Sudden Cardiac Death in Non-Smoking Individuals: The Atherosclerosis Risk in Communities Study
2013
Management of Syncope in Adults: An Update
2008
Subclinical and Device-Detected Atrial Fibrillation: Pondering the Knowledge Gap: A Scientific Statement From the American Heart Association
2019
A Common Polymorphism in SCN5A is Associated with Lone Atrial Fibrillation
2006
Cardiac Autonomic Dysfunction and Incidence of Atrial Fibrillation
2017
Novel Association between Plasma Matrix Metalloproteinase-9 and Risk of Incident Atrial Fibrillation in a Case-Cohort Study: The Atherosclerosis Risk in Communities Study
2013
In-hospital and long-term outcomes of multivessel percutaneous coronary revascularization after acute myocardial infarction
2005
Prevalence and Clinical Outcomes of Patients With Multiple Potential Causes of Syncope
2003
Comparable Ascertainment of Newly-Diagnosed Atrial Fibrillation Using Active Cohort Follow-Up versus Surveillance of Centers for Medicare and Medicaid Services in the Atherosclerosis Risk in Communities Study
2014
Preserved Left Ventricular Ejection Fraction Following Atrioventricular Junction Ablation and Pacing for Atrial Fibrillation
2007
Epidemiology of atrial fibrillation: A current perspective
2006
2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation
2019
Atrial Fibrillation Burden: Moving Beyond Atrial Fibrillation as a Binary Entity: A Scientific Statement From the American Heart Association
2018
Obesity related risk of sudden cardiac death in the atherosclerosis risk in communities study
2014
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2019 Standout
Pacing as a Treatment for Reflex-Mediated (Vasovagal, Situational, or Carotid Sinus Hypersensitivity) Syncope: A Systematic Review for the 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope
2017
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons
2019 Standout
Comparative effectiveness of direct oral anticoagulants and warfarin in patients with cancer and atrial fibrillation
2018
Association of Antidepressant Medication Type With the Incidence of Cardiovascular Disease in the ARIC Study
2019
Circulating levels of liver enzymes and incidence of atrial fibrillation: the Atherosclerosis Risk in Communities cohort
2014
Prediction of Atrial Fibrillation in a Racially Diverse Cohort: The Multi‐Ethnic Study of Atherosclerosis (MESA)
2016
Pacing as a Treatment for Reflex-Mediated (Vasovagal, Situational, or Carotid Sinus Hypersensitivity) Syncope: A Systematic Review for the 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society
2017
Physical Activity, Obesity, Weight Change, and Risk of Atrial Fibrillation
2014
Standard Medical Management in Secondary Prevention of Ischemic Stroke in China (SMART)
2011
Atrial Fibrillation and Risk of ST-Segment–Elevation Versus Non–ST-Segment–Elevation Myocardial Infarction
2015
Rankless by CCL
2026